Liver Failure & Liver Disease

You have full text access to this OnlineOpen article

Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach

  1. Soek Ying Neo1,
  2. Chon Kar Leow1,2,
  3. Vinsensius B. Vega1,
  4. Philip M. Long1,
  5. Amirul F.M. Islam1,
  6. Paul B.S. Lai3,
  7. Edison T. Liu1,
  8. Ee Chee Ren1,4,†,*

Article first published online: 25 MAR 2004

DOI: 10.1002/hep.20105

Issue

Hepatology

Hepatology

Volume 39, Issue 4, pages 944–953, April 2004

Additional Information

How to Cite

Neo, S. Y., Leow, C. K., Vega, V. B., Long, P. M., Islam, A. F.M., Lai, P. B.S., Liu, E. T. and Ren, E. C. (2004), Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology, 39: 944–953. doi: 10.1002/hep.20105

Author Information

  1. 1

    Genome Institute of Singapore, Singapore

  2. 2

    Department of Surgery, National University Hospital, Singapore

  3. 3

    Department of Surgery, Prince of Wales Hospital, Hong Kong, People's Republic of China

  4. 4

    Department of Microbiology, National University of Singapore, Singapore

  1. †

    fax: 011-65-6478-9052

*Genome Institute of Singapore, 60 Biopolis Street, The Genome, 02-01, Singapore 138672

Publication History

  1. Issue published online: 25 MAR 2004
  2. Article first published online: 25 MAR 2004
  3. Manuscript Accepted: 20 DEC 2003
  4. Manuscript Received: 18 SEP 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (338K)

References

  • 1
    Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA 1999; 49: 33–64.
  • 2
    Yu AS, Keeffe EB. Management of hepatocellular carcinoma. Rev Gastroenterol Disord 2003; 3: 8–24.
  • 3
    Bosl GJ, Head MD. Serum tumor marker half-life during chemotherapy in patients with germ cell tumors. Int J Biol Markers 1994; 9: 25–28.
  • 4
    Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733–1745.
  • 5
    Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet 1999; 21( Suppl): 33–37.
  • 6
    Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001; 61: 2129–2137.
  • 7
    Honda M, Kaneko S, Kawa H, Shirota Y, Kobayashi K. Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology 2001; 120: 955–966.
  • 8
    Shirota Y, Kaneko S, Honda M, Kawai HF, Kobayashi K. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. HEPATOLOGY 2001; 33: 832–840.
    Direct Link:
  • 9
    Tackels-Horne D, Goodman MD, Williams AJ, Wilson DJ, Eskandari T, Vogt LM, Boland JF, et al. Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling. Cancer 2001; 92: 395–405.
    Direct Link:
  • 10
    Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, et al. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 2001; 61: 3176–3781.
  • 11
    Xu X-R, Huang J, Xu Z-G, Qian B-Z, Zhu Z-D, Yan Q, Cai T, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 2001; 98: 15089–15094.
  • 12
    Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai K-M, et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002; 13: 1929–1939.
  • 13
    Eberwine J, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R, Zettel M, et al. Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA 1992; 89: 3010–3014.
  • 14
    Sotiriou C, Khanna C, Jazaeri AA, Petersen D, Liu ET. Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays. J Mol Diag 2002; 4: 30–36.
  • 15
    Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863–14688.
  • 16
    The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat Genet 2000; 25: 25–29. (Available: URL: http://www.geneontology.org).
  • 17
    Davison AC, Hinkley DV. Bootstrap methods and their application. Cambridge: Cambridge University Press, 1997.
  • 18
    Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chrom Cancer 1997; 18: 59–65.
    Direct Link:
  • 19
    Raaphorst FM, van Kemenade FJ, Blokzijl T, Fieret E, Hamer KM, Satijn DPE, Otte AP, et al. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol 2000; 157: 709–715.
  • 20
    Kishima Y, Yoshida K, Enomoto H, Yamamoto M, Kuroda T, Okuda Y, Uyama H, et al. Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells. Hepatogastroenterology 2002; 49: 1639–1644.
  • 21
    Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KK. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab 2000; 85: 4712–4720.
  • 22
    Zhang N, Deuel TF. Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors. Curr Opin Hematol 1999; 6: 44–50.
  • 23
    Irniger S, Nasmyth K. The anaphase-promoting complex is required in G1 arrested yeast cells to inhibit B-type cyclin accumulation and to prevent uncontrolled entry into S-phase. J Cell Sci 1997; 110: 1523–1531.
  • 24
    Johnson PJ. The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 2001; 5: 145–159.
  • 25
    Huynh H, Chow PKH, Ooi LLP, Soo K-C. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. Cell Growth Diff 2002; 13: 115–122.
  • 26
    Ito Y, Takeda T, Sakon M, Tsujimoto M, Higashiyama S, Noda K, Miyoshi E, et al. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Br J Cancer 2001; 84: 1377–1383.
  • 27
    Riese DJII, Stern DF. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 1998; 20: 41–48.
    Direct Link:
  • 28
    Salomoni P, Pandolfi PP. p53 de-ubiquitination: at the edge between life and death. Nat Cell Biol 2002; 4: E152–E153.
  • 29
    Pickart CM. Ubiquitin enters the new millennium. Mol Cell 2001; 8: 499–504.
  • 30
    Salghetti SE, Caudy AA, Chenoweth JG, Tansey WP. Regulation of transcriptional activation domain function by ubiquitin. Science 2001; 293: 1651–1653.
  • 31
    Sakamoto KM. Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies. Mol Genet Metab 2002; 77: 44–56.
  • 32
    Nawrocki ST, Bruns CJ, Harbison MT, Bold RJ, Gotsch BS, Abbruzzese JL, Elliott P, et al. Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther 2002; 1: 1243–1253.
  • 33
    Carver RS, Sliwkowski MX, Sitaric C, Russell WE. Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes. J Biol Chem 1996; 271: 13491–13496.
  • 34
    Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signaling during tumor progression. EMBO J 2003; 22: 2318–2323.
  • 35
    Masumoto A, Arao S, Otsuki M. Role of β1 integrins in adhesion and invasion of hepatocellular cells. HEPATOLOGY 1999; 29: 68–74.
    Direct Link:
  • 36
    Jiang J, Yu L, Huang X, Chen X, Li D, Zhang Y, Tang L, et al. Identification of two novel human dynein light chain genes, DNLC2A and DNLC2B, and their expression changes in hepatocellular carcinoma tissues from 68 Chinese patients. Gene 2001; 281: 103–113.
  • 37
    Smith JW. Cilengitide Merck. Curr Opin Invest Drugs 2003; 4: 741–745.
  • 38
    Orlando V. Polycomb, epigenomes and control of cell identity. Cell 2003; 112: 599–606.
  • 39
    Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419: 624–629.
  • 40
    Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003; 423: 255–260.
  • 41
    Fürstenberger G, Senn H. Insulin-like growth factors and cancer. Lancet Oncol 2002; 3: 298–302.
  • 42
    Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 2000; 183: 1–9.
    Direct Link:
  • 43
    Saikali Z, Sinnett D. Expression of glypican 3 (GPC3) in embryonal tumors. Int J Cancer 2000; 89: 418–422.
    Direct Link:
  • 44
    Xiang YY, Ladeda V, Filmus J. Glypican-3 expression is silenced in human breast cancer. Oncogene 2001; 20: 7408–7412.
  • 45
    Filmus J, Selleck SB. Glypicans: proteoglycans with a surprise. J Clin Invest 2001; 108: 497–501.
  • 46
    Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, et al. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer 2003; 103: 455–465.
    Direct Link:
  • 47
    Lee J-S, Thorgeirsson SS. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. HEPATOLOGY 2002; 35: 1134–1143.
    Direct Link:
  • 48
    Zimonjic DB, Keck CL, Thorgeirsson SS, Popescu NC. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. HEPATOLOGY 1999; 29: 1208–1214.
    Direct Link:
View Full Article with Supporting Information (HTML) Get PDF (338K)